Michelle Mello

Q: What Schools Are Affiliated With Michelle Mello

Michelle Mello is affiliated with the following schools: Yale University, University of Melbourne, Stanford University, Harvard University

Michelle Mello's AcademicInfluence.com Rankings

Michelle Mello

Law

#2670

World Rank

#3318

Historical Rank

International Law

#689

World Rank

#850

Historical Rank

law Degrees

Download Badge

Why Is Michelle Mello Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Michelle Marie Mello is an American empirical health law scholar. She is a Full Professor of Law at Stanford Law School and a Full Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine. In 2013, Mello was elected a member of the Institute of Medicine.

(See a Problem?)

Michelle Mello's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. (2005) (1106)
Claims, errors, and compensation payments in medical malpractice litigation. (2006) (749)
National costs of the medical liability system. (2010) (437)
The Havasupai Indian tribe case--lessons for research involving stored biologic samples. (2010) (317)
Obesity--the new frontier of public health law. (2006) (229)
Diagnostic Testing for the Novel Coronavirus. (2020) (214)
Thinking Globally, Acting Locally - The U.S. Response to Covid-19. (2020) (201)
Conflict in the care of patients with prolonged stay in the ICU: types, sources, and predictors (2003) (190)
Making the case for laws that improve health: a framework for public health law research. (2010) (168)
The role of medical liability reform in federal health care reform. (2009) (166)
Relationship Between Malpractice Litigation Pressure and Rates of Cesarean Section and Vaginal Birth After Cesarean Section (2009) (166)
The new medical malpractice crisis. (2003) (162)
Preparing for responsible sharing of clinical trial data. (2013) (153)
Nature of conflict in the care of pediatric intensive care patients with prolonged stay. (2003) (148)
Deterrence of Medical Errors: Theory and Evidence for Malpractice Reform (2002) (147)
Physicians' fears of malpractice lawsuits are not assuaged by tort reforms. (2010) (136)
Clinical Trial Participants’ Views of the Risks and Benefits of Data Sharing (2018) (134)
Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution. (2005) (134)
Disclosure of medical injury to patients: an improbable risk management strategy. (2007) (128)
Advising patients about patient safety: current initiatives risk shifting responsibility. (2005) (127)
Academic medical centers' standards for clinical-trial agreements with industry. (2005) (125)
Incidental Findings in Human Subjects Research: What Do Investigators Owe Research Participants? (2008) (118)
Caring for patients in a malpractice crisis: physician satisfaction and quality of care. (2004) (114)
Surgical residents' perceptions of the effects of the ACGME duty hour requirements 1 year after implementation. (2005) (113)
Of Swords and Shields: The Role of Clinical Practice Guidelines in Medical Malpractice Litigation (2001) (111)
Do Medicare HMOs still reduce health services use after controlling for selection bias? (2002) (106)
HPV vaccination mandates--lawmaking amid political and scientific controversy. (2010) (105)
A new era in noninvasive prenatal testing. (2013) (103)
Understanding biased selection in Medicare HMOs. (2003) (103)
HIPAA and Protecting Health Information in the 21st Century (2018) (101)
The interplay of public health law and industry self-regulation: the case of sugar-sweetened beverage sales in schools. (2008) (100)
Work hours reform: perceptions and desires of contemporary surgical residents. (2003) (99)
Implementing Resident Work Hour Limitations: Lessons from the New York State Experience (2003) (99)
New directions in medical liability reform. (2011) (98)
Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages. (2018) (97)
Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints (2011) (97)
The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer. (2001) (96)
Ethics and governance for digital disease surveillance (2020) (95)
Half-baked--the retail promotion of marijuana edibles. (2015) (88)
Results of a clinical trial on care improvement for the critically ill (2003) (88)
Effects of a Malpractice Crisis on Specialist Supply and Patient Access to Care (2005) (87)
The flaws in state 'apology' and 'disclosure' laws dilute their intended impact on malpractice suits. (2010) (87)
The medical liability climate and prospects for reform. (2014) (87)
Medical malpractice liability in the age of electronic health records. (2010) (86)
Wellness programs and lifestyle discrimination--the legal limits. (2008) (85)
Communication-and-resolution programs: the challenges and lessons learned from six early adopters. (2014) (82)
Medical malpractice: impact of the crisis and effect of state tort reforms. (2006) (80)
High physician concern about malpractice risk predicts more aggressive diagnostic testing in office-based practice. (2013) (80)
Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry — Self-Regulation in the Shadow of Federal Prosecution (2004) (79)
Reduced Medicolegal Risk by Compliance With Obstetric Clinical Pathways: A Case–Control Study (2003) (78)
Regulation of smoking in public housing. (2010) (77)
Ensuring Uptake of Vaccines against SARS-CoV-2. (2020) (74)
"Health courts" and accountability for patient safety. (2006) (73)
The role of clinical guidelines in medical negligence litigation: a shift from the Bolam standard? (2006) (72)
Talking with patients about other clinicians' errors. (2013) (70)
The McLawsuit: the fast-food industry and legal accountability for obesity. (2003) (69)
Beyond negligence: avoidability and medical injury compensation. (2008) (66)
Medical malpractice. (2004) (65)
Who Pays for Medical Errors? An Analysis of Adverse Event Costs, the Medical Liability System, and Incentives for Patient Safety Improvement (2007) (64)
Shifting Vaccination Politics--The End of Personal-Belief Exemptions in California. (2015) (64)
What is a public health "emergency"? (2014) (64)
Drug Companies' Liability for the Opioid Epidemic. (2017) (62)
Big Data, Big Tech, and Protecting Patient Privacy. (2019) (62)
Sociodemographic Predictors of Vaccination Exemptions on the Basis of Personal Belief in California. (2016) (60)
Managing the Risks of Concurrent Surgeries. (2016) (58)
Shifting terrain in the regulation of off-label promotion of pharmaceuticals. (2009) (58)
Association of Overlapping Surgery With Perioperative Outcomes (2019) (58)
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA (2021) (57)
Whistle-blowers' experiences in fraud litigation against pharmaceutical companies. (2010) (56)
Disclosure, apology, and offer programs: stakeholders' views of barriers to and strategies for broad implementation. (2012) (56)
Legal Barriers to the Growth of Health Information Exchange-Boulders or Pebbles? (2018) (55)
Are damages caps regressive? A study of malpractice jury verdicts in California. (2004) (54)
Confidentiality laws and secrecy in medical research: improving public access to data on drug safety. (2007) (54)
The Rise of Litigation in Human Subjects Research (2003) (53)
Prevalence and Characteristics of Physicians Prone to Malpractice Claims. (2016) (53)
Gene patenting--the Supreme Court finally speaks. (2013) (50)
Survey finds public support for legal interventions directed at health behavior to fight noncommunicable disease. (2013) (49)
Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey (2017) (48)
Sunlight as disinfectant--new rules on disclosure of industry payments to physicians. (2013) (47)
Patient Safety and Medical Malpractice: A Case Study (2003) (47)
Effects of a Professional Liability Crisis on Residents’ Practice Decisions (2005) (47)
Respecting Disability Rights - Toward Improved Crisis Standards of Care. (2020) (47)
Relationship between quality of care and negligence litigation in nursing homes. (2011) (46)
Fostering rational regulation of patient safety. (2005) (46)
Biomedical ethics. (1986) (45)
Pharmaceutical companies' role in state vaccination policymaking: the case of human papillomavirus vaccination. (2012) (45)
New York City's war on fat. (2009) (45)
Comparison of medical and nursing attitudes to resuscitation and patient autonomy between a British and an American teaching hospital. (1998) (45)
Implementing resident work hour limitations: lessons from the New York State experience. (2003) (45)
Assessment of Out-of-Network Billing for Privately Insured Patients Receiving Care in In-Network Hospitals. (2019) (44)
Disclosing harmful medical errors to patients: tackling three tough cases. (2009) (42)
Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies (2017) (42)
Patients’ Experiences With Communication-and-Resolution Programs After Medical Injury (2017) (42)
Have Tobacco 21 Laws Come of Age? (2016) (40)
Tobacco 21--an idea whose time has come. (2014) (40)
Attacks on Public Health Officials During COVID-19. (2020) (40)
Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices (2019) (40)
How policy makers can smooth the way for communication-and- resolution programs. (2014) (38)
Understanding medical malpractice insurance: a primer. (2006) (37)
Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape (2015) (37)
Malpractice Liability and Health Care Quality: A Review. (2020) (35)
Implementing hospital-based communication-and-resolution programs: lessons learned in New York City. (2014) (34)
The Evolving Story of Overlapping Surgery. (2017) (34)
Advance care planning in patients undergoing hematopoietic cell transplantation. (2007) (33)
Geographic Variation in Informed Consent Law: Two Standards for Disclosure of Treatment Risks (2007) (33)
The politics of HPV vaccination policy formation in the United States. (2013) (33)
Malpractice reform--opportunities for leadership by health care institutions and liability insurers. (2010) (32)
Federal trade commission regulation of food advertising to children: possibilities for a reinvigorated role. (2010) (32)
Searching for Public Health Law’s Sweet Spot: The Regulation of Sugar-Sweetened Beverages (2015) (32)
The role of law in public health: the case of family planning in the Philippines. (2006) (32)
Changes in physician supply and scope of practice during a malpractice crisis: evidence from Pennsylvania. (2007) (31)
Improving reconciliation following medical injury: a qualitative study of responses to patient safety incidents in New Zealand (2017) (31)
Medical Malpractice Liability in the Age of Electronic Health Records (2011) (30)
Deconstructing Negligence: The Role of Individual and System Factors in Causing Medical Injuries (2008) (30)
US Nationwide Disclosure of Industry Payments and Public Trust in Physicians (2019) (29)
Ethical considerations in studying drug safety--the Institute of Medicine report. (2012) (28)
Direct-to-consumer advertising and shared liability for pharmaceutical manufacturers. (2003) (28)
Critical opportunities for public health law: a call for action. (2013) (27)
A Longitudinal Analysis of the Impact of Liability Pressure on the Supply of Obstetrician‐Gynecologists (2008) (27)
Disclosure-and-resolution programs that include generous compensation offers may prompt a complex patient response. (2012) (27)
Defensive medicine--legally necessary but ethically wrong?: Inpatient stress testing for chest pain in low-risk patients. (2013) (26)
Medical malpractice as an epidemiological problem. (2004) (26)
The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs. (2004) (26)
Administrative compensation for medical injuries: lessons from three foreign systems. (2011) (26)
Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA (2021) (25)
Effects Of A Communication-And-Resolution Program On Hospitals' Malpractice Claims And Costs. (2018) (25)
Outcomes In Two Massachusetts Hospital Systems Give Reason For Optimism About Communication-And-Resolution Programs. (2017) (25)
"Pay for delay" settlements of disputes over pharmaceutical patents. (2011) (25)
The Leapfrog standards: ready to jump from marketplace to courtroom? (2003) (25)
Rationalizing Vaccine Injury Compensation (2007) (25)
When Tort Resolutions Are “Wrong”: Predictors of Discordant Outcomes in Medical Malpractice Litigation (2007) (25)
Gene patenting--is the pendulum swinging back? (2010) (24)
Effect of the public disclosure of industry payments information on patients: results from a population-based natural experiment (2019) (23)
Decision making and satisfaction with care in the pediatric intensive care unit: Findings from a controlled clinical trial (2004) (22)
The Missing Piece - SARS-CoV-2 Testing and School Reopening. (2020) (22)
Supporting Those Who Go to Fight Ebola (2015) (21)
Malpractice reform--opportunities for leadership by health care institutions and liability insurers. (2010) (21)
Adjudicating Severe Birth Injury Claims in Florida and Virginia: The Experience of a Landmark Experiment in Personal Injury Compensation (2008) (21)
Challenges of Implementing a Communication-and-Resolution Program Where Multiple Organizations Must Cooperate. (2016) (20)
Standing Up against Gender Bias and Harassment - A Matter of Professional Ethics. (2020) (20)
Legal concerns and the influenza vaccine shortage. (2005) (20)
Defensive Medicine and Tort Reform: A Wide View (2010) (20)
Changes in Practice among Physicians with Malpractice Claims (2019) (19)
The future of surgery: today's residents speak. (2005) (18)
Sunshine laws and the pharmaceutical industry. (2007) (17)
Medical malpractice - april 2011 update. (2011) (17)
Administrative compensation of medical injuries: a hardy perennial blooms again. (2008) (17)
Partitioning the Curve - Interstate Travel Restrictions During the Covid-19 Pandemic. (2020) (17)
Behind Schedule - Reconciling Federal and State Marijuana Policy. (2018) (17)
Legal and Policy Interventions to Improve Patient Safety. (2016) (17)
Empirical Health Law Scholarship: The State of the Field (2009) (16)
Can Communication-And-Resolution Programs Achieve Their Potential? Five Key Questions. (2018) (16)
Breast cancer screening: conflicting guidelines and medicolegal risk. (2013) (16)
Case Outcomes in a Communication-and-Resolution Program in New York Hospitals. (2016) (16)
Vaccination without Litigation - Addressing Religious Objections to Hospital Influenza-Vaccination Mandates. (2018) (15)
Obesity—personal choice or public health issue? (2008) (15)
Due process in investigations of research misconduct. (2003) (15)
Medical-process patents--monopolizing the delivery of health care. (2006) (15)
Hospitals' behavior in a tort crisis: observations from Pennsylvania. (2003) (14)
Compact versus contract--industry sponsors' obligations to their research subjects. (2007) (14)
FDA regulation of off-label drug promotion under attack. (2013) (13)
Researchers’ Views of the Acceptability of Restrictive Provisions in Clinical Trial Agreements with Industry Sponsors (2005) (13)
Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs (2021) (13)
School Reopenings and the Community During the COVID-19 Pandemic. (2020) (13)
Restrictions on the use of prescribing data for drug promotion. (2011) (13)
Relationship Between State Malpractice Environment and Quality of Health Care in the United States. (2017) (13)
Collaboration with Regulators to Support Quality and Accountability Following Medical Errors: The Communication and Resolution Program Certification Pilot. (2016) (12)
Ethics of randomized trials in a public health emergency (2018) (12)
Incentives for COVID-19 vaccination (2022) (12)
Association Between State Medical Malpractice Environment and Surgical Quality and Cost in the United States (2016) (11)
Medical Liability - Prospects for Federal Reform. (2017) (11)
Waiting for data: Barriers to executing data use agreements (2020) (10)
Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA (2022) (10)
Regulatory and judicial oversight of nonprofit hospitals. (2007) (10)
Are Medical Malpractice Damages Caps Constitutional? An Overview of State Litigation (2005) (10)
Ensuring successful implementation of communication-and-resolution programmes (2020) (9)
New horizons in pharmaceutical regulation (2012) (9)
Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines. (2021) (9)
Building a National Surveillance System for Malpractice Claims. (2016) (9)
Policing Medicaid and Medicare Managed Care: The Role of Courts and Administrative Agencies (2002) (9)
Rationalizing Noneconomic Damages: A Health Utilities Approach (2011) (9)
Prospects for Regulation of Off-Label Drug Promotion in an Era of Expanding Commercial Speech Protection (2014) (8)
Protecting the Privacy of Reproductive Health Information After the Fall of Roe v Wade. (2022) (8)
How US law will evaluate artificial intelligence for covid-19 (2021) (8)
Using Statistical Evidence to Prove the Malpractice Standard of Care: Bridging Legal, Clinical, and Statistical Thinking (2002) (7)
Medical Malpractice and the U.S. Health Care System: The Medical Malpractice System: Structure and Performance (2006) (7)
Institutional Oversight of Faculty-Industry Consulting Relationships in U.S. Medical Schools: A Delphi Study (2015) (7)
Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis (2021) (7)
Plugging the gap--diabetes. (1992) (7)
Medical monitoring for pharmaceutical injuries: tort law for the public's health? (2003) (7)
Spillover effects of state mandated benefit laws: the case of outpatient breast cancer surgery. (2009) (7)
Assessment of Perioperative Outcomes Among Surgeons Who Operated the Night Before. (2022) (6)
In search of global governance for research in epidemics (2017) (6)
The Legal Authority for States' Stay-at-Home Orders. (2020) (6)
Legal and policy approaches to the obesity epidemic. (2012) (6)
Liability, Patient Safety, and Defensive Medicine What Does the Future Hold? (2006) (5)
Incorporating Health Equity Into COVID-19 Reopening Plans: Policy Experimentation in California. (2021) (5)
Disclosure: The Authors Respond (2007) (5)
What Makes Ensuring Access to Affordable Prescription Drugs the Hardest Problem in Health Policy (2018) (5)
Effects of Federal Mental Health Parity on Mental Health Care Use and Spending (2015) (5)
When Physicians Engage in Practices That Threaten the Nation's Health. (2021) (5)
Public Health Law after Covid-19. (2021) (5)
Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues. (2018) (5)
Should Malpractice Settlements Be Secret? (2015) (5)
Commentary: A legal perspective on diabetes surveillance--privacy and the police power. (2009) (4)
Do you mind if I record?: Perceptions and practice regarding patient requests to record clinic visits in oncology (2021) (4)
Narrowing Vaccination Exemption Laws: Lessons From California and Beyond (2020) (4)
Testing the Immunity of the Firearm Industry to Tort Litigation (2017) (4)
Incorporating Health Equity Into COVID-19 Reopening Plans: Policy Experimentation in California. (2021) (4)
Multilevel legal approaches to obesity prevention: A conceptual and methodological toolkit (2019) (4)
The legacy of the COVID-19 pandemic for childhood vaccination in the USA (2022) (4)
Medical malpractice in the military. (2011) (4)
Making the case for health-enhancing laws after Bloomberg. (2014) (4)
The taxing power and the public's health. (2012) (3)
STATES WITH OVERALL ROBUST PRESCRIPTION DRUG MONITORING PROGRAMS EXPERIENCED REDUCTIONS IN OPIOIDS PRESCRIBED TO COMMERCIALLY-INSURED INDIVIDUALS (2018) (3)
Commentary: How Should Hospitals Respond to Surgeons’ Requests to Schedule Overlapping Surgeries? (2018) (3)
Legal Strategies for Reining in 'Unconscionable' Prices for Prescription Drugs (2019) (3)
Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional study (2023) (3)
Incremental health care reform. (2009) (3)
Medical malpractice — Update (2011) (3)
Prospects for Enforcing Prohibitions on Off-Label Drug Promotion after United States v. Caronia: An Analysis of Litigated Cases. (2021) (3)
Demystifying the law/science disconnect. (2001) (3)
Drug Pricing Reform in 2021-Going Big or Going Bipartisan? (2021) (2)
Association of Federal Mental Health Parity Legislation With Health Care Use and Spending Among High Utilizers of Services (2019) (2)
Barriers to Ensuring Access to Affordable Prescription Drugs. (2020) (2)
Beyond financial conflicts of interest: Institutional oversight of faculty consulting agreements at schools of medicine and public health (2018) (2)
To Address Drug Affordability, Grab the Low-hanging Fruit. (2021) (2)
In From the Cold? Law's Evolving Role in Patient Safety (2019) (2)
Death, life, and uncertainty: allocating the risk of error in the decision to terminate life support. (1999) (2)
Vaccine Misinformation and the First Amendment-The Price of Free Speech. (2022) (2)
When are primary care physicians untruthful with patients? A qualitative study (2017) (2)
Are nurses engaged in quality initiatives? (2011) (2)
Practising personalised care. (2020) (2)
U.S. Public Health Law - Foundations and Emerging Shifts. (2022) (2)
‘Poking the Skunk’: Ethical and Medico‐Legal Concerns in Research About Patients’ Experiences of Medical Injury (2019) (2)
Energise for excellence in care: a call to action for nurses and midwives. (2012) (2)
Far More Transparency is Needed for COVID-19 Vaccine Trials (2020) (2)
Health Policy Review (2005) (2)
Apology laws and malpractice liability: what have we learned? (2020) (2)
The Public Health Fixes That Missed the Omnibus. (2023) (1)
HIPAA in the Era of Data Sharing-Reply. (2020) (1)
Ensuring Access to Affordable Prescription Drugs—the National Academies of Sciences, Engineering and Medicine’s Report (2018) (1)
The Political and Judicial Battles Over Mask Mandates for Schools. (2021) (1)
Caring for Patients in a Malpractice Crisis: Physician Satisfaction, the Physician-Patient Relationship, and Quality of Care (2004) (1)
Assessing Patients' Experiences with Medical Injury Reconciliation Processes: Item Generation for a Novel Survey Questionnaire. (2021) (1)
Hospitals' Behavior In A Tort Crisis: (2003) (1)
Nutrition: Ejecting trans fat from New York City restaurants (2012) (1)
Managing Malpractice Crises (2005) (1)
The Experience of a Community Representative on an Ethics Consult Team (2004) (1)
Medical Monitoring for Pharmaceutical Injuries (2003) (1)
Population health science as a unifying foundation for translational clinical and public health research (2022) (1)
Clinical trials and the right to remain silent. (2014) (1)
The Fresh Assault on Insurance Coverage Mandates. (2022) (1)
Innovation Policy Pluralism (2019) (0)
About Communication-And-Resolution Programs Outcomes In Two Massachusetts Hospital Systems Give Reason For Optimism (2017) (0)
SEVERE PERICARDIAL EFFUSION IN ERASMUS SYNDROME (2021) (0)
Discharging Patients Against Medical Advice. (2023) (0)
Medical liability and reporting malpractice payments--reply. (2015) (0)
Commentary: Demystifying the Law/Science Disconnect (2001) (0)
Supporting Hospitals During a New Wave of COVID-19. (2021) (0)
PharmaceuticalCompanies'RoleinStateVaccination Policymaking:TheCaseofHumanPapillomavirus Vaccination (2012) (0)
Oncologist experiences regarding patient-recorded clinical encounters: Implications for the patient-doctor relationship. (2020) (0)
Liability for Adverse Events in Direct-to-Consumer Advertising (2003) (0)
The Role of Transparency in Patient Safety Improvement (2019) (0)
Examining Opportunities to Increase Savings From Medicare Price Negotiations. (2023) (0)
Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era (2023) (0)
Length of Stay After Overlapping Surgery-Reply. (2017) (0)
Avoiding Malpractice Suits: The Authors Reply. (2018) (0)
PO301 Moking Women With Multimorbidities in the Smoking Cessation Process (2018) (0)
Resuscitating Abortion Rights in Emergency Care. (2022) (0)
Public Health Law Research: Editor's Introduction (2013) (0)
Editors' Introduction (2009) (0)
Correlation between the learning curve and the pain reported by the patient during outpatient hysteroscopy procedure without anesthesia (2014) (0)
BEHCET’S DISEASE AND SEVERE REACTION TO 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE: A CASE REPORT (2021) (0)
To Address Drug Affordability, Grab the Low-Hanging Fruit. (2021) (0)
Audio Interview: The Legal Basis for Covid-19 Restrictions and Mandates. (2021) (0)
The Leapfrog Standards : Ready To Jump FromMarketplace To Courtroom ? Using the tort system to enforce aspirational standards of care may inhibit achieving greater patient safety (2003) (0)
Covid-19 Pandemic Priorities for President-Elect Biden (2020) (0)
Mainstreaming Wastewater Surveillance for Infectious Disease. (2023) (0)
60 second with Michelle Mello. (2015) (0)
Creative People and Industries for Growth and Development : A case study of the municipality of Kalmar (2013) (0)
The Source Roundup: September 2018 Edition (2020) (0)
"We can put our heads down and do nothing--or we can take action". (2011) (0)
Personalised solutions through social prescribing. (2021) (0)
Effects of Robust State Prescription Drug Monitoring Programs on Opioid Prescribing and Use (2017) (0)
What Patients Expect and Deserve-Reply. (2018) (0)
Association of Unsolicited Patient Observations With the Quality of a Surgeon's Care. (2017) (0)
PO393 Chronic Kidney Disease in Smokers with Multiple Chronic Diseases (2018) (0)
Agenda Setting for Public Health Law: Identifying Critical Opportunities (2014) (0)
Patient and Family Involvement (2005) (0)
Public Health Law Modernization 2.0: Rebalancing Public Health Powers And Individual Liberty In The Age Of COVID-19. (2023) (0)
The Medical Liability Environment: Is It Really Any Worse for Hospitalists? (2021) (0)
SYSTEMIC LUPUS ERYTHEMATOSUS AS A PARANEOPLASTIC MANIFESTATION OF BREAST CANCER: A CASE REPORT (2021) (0)
CARDIAC TAMPONADE AS INITIAL MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS: REPORT OF TWO CASES. (2019) (0)
LIPODYSTROPHIC SYNDROME ASSOCIATED WITH DERMATOMYOSITIS. (2019) (0)
PERNICIOUS ANEMIA: A RARE CAUSE OF ANEMIA IN SYSTEMIC LUPUS ERYTHEMATOSUS (2019) (0)
HEART TRANSPLANTATION FOR LEFT VENTRICULAR PSEUDOANEURYSM IN BEHCET'S DISEASE (2022) (0)
MACROPHAGE ACTIVATION SYNDROME IN A PATIENT WITH A RECENT DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS – A REPORT OF SUCCESSFUL TREATMENT WITH DEXAMETHASONE AND HUMAN IMMUNOGLOBULIN (2022) (0)
Shrinking lung syndrome in overlapping Systemic Lupus Erythematosus and Systemic Sclerosis: a case report (2021) (0)
Health Affairs From Six Early Adopters Communication-And-Resolution Programs : The Challenges And Lessons Learned (2013) (0)
Prevalence and Characteristics of Physicians Prone to Malpractice Claims EDITORIAL COMMENT (2016) (0)
A new era in noninvasive prenatal testing. (2013) (0)
Economic Incentives for Patient Safety Improvement: An Analysis of Hospital Adverse Event Costs and Where They Fall (2006) (0)

This paper list is powered by the following services:

Other Resources About Michelle Mello

What Schools Are Affiliated With Michelle Mello?

Michelle Mello is affiliated with the following schools: